This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT05537571
Recruitment Status : Active, not recruiting
First Posted : September 13, 2022
Last Update Posted : May 24, 2023
Information provided by (Responsible Party):
Silence Therapeutics plc

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 2024
Estimated Study Completion Date : June 2024